PMC:7321036 / 41929-42122 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T340","span":{"begin":56,"end":60},"obj":"Body_part"},{"id":"T341","span":{"begin":76,"end":81},"obj":"Body_part"}],"attributes":[{"id":"A340","pred":"fma_id","subj":"T340","obj":"http://purl.org/sig/ont/fma/fma67122"},{"id":"A341","pred":"fma_id","subj":"T341","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":", Related to Figure 6\n(A) RT-qPCR analysis of indicated mRNA from A549-ACE2 cells pre-treated with p38 inhibitor SB203580 at indicated concentrations for one hour prior to infection with SARS-C"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T201","span":{"begin":172,"end":181},"obj":"Disease"}],"attributes":[{"id":"A201","pred":"mondo_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":", Related to Figure 6\n(A) RT-qPCR analysis of indicated mRNA from A549-ACE2 cells pre-treated with p38 inhibitor SB203580 at indicated concentrations for one hour prior to infection with SARS-C"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T487","span":{"begin":23,"end":24},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T488","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0001601"},{"id":"T489","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0050025"},{"id":"T490","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0054264"},{"id":"T491","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0054265"},{"id":"T492","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0054266"},{"id":"T493","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0054267"},{"id":"T494","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0054268"},{"id":"T495","span":{"begin":66,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0054269"},{"id":"T496","span":{"begin":76,"end":81},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":", Related to Figure 6\n(A) RT-qPCR analysis of indicated mRNA from A549-ACE2 cells pre-treated with p38 inhibitor SB203580 at indicated concentrations for one hour prior to infection with SARS-C"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T287","span":{"begin":103,"end":112},"obj":"Chemical"},{"id":"T288","span":{"begin":113,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A287","pred":"chebi_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A288","pred":"chebi_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/CHEBI_90705"}],"text":", Related to Figure 6\n(A) RT-qPCR analysis of indicated mRNA from A549-ACE2 cells pre-treated with p38 inhibitor SB203580 at indicated concentrations for one hour prior to infection with SARS-C"}

{"project":"LitCovid-PubTator","denotations":[{"id":"808","span":{"begin":99,"end":102},"obj":"Gene"},{"id":"810","span":{"begin":113,"end":121},"obj":"Chemical"},{"id":"812","span":{"begin":172,"end":181},"obj":"Disease"},{"id":"814","span":{"begin":66,"end":75},"obj":"CellLine"}],"attributes":[{"id":"A808","pred":"tao:has_database_id","subj":"808","obj":"Gene:5594"},{"id":"A810","pred":"tao:has_database_id","subj":"810","obj":"MESH:C093642"},{"id":"A812","pred":"tao:has_database_id","subj":"812","obj":"MESH:D007239"},{"id":"A814","pred":"tao:has_database_id","subj":"814","obj":"CVCL:0023"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", Related to Figure 6\n(A) RT-qPCR analysis of indicated mRNA from A549-ACE2 cells pre-treated with p38 inhibitor SB203580 at indicated concentrations for one hour prior to infection with SARS-C"}